Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Murphy, Philip M
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
W
Anginot A
,
Nguyen J
,
Nader ZAbou
,
Rondeau V
,
Bonaud A
,
Kalogeraki M
,
Boutin A
,
Lemos JP
,
Bisio V
,
Koenen J
, et al.
WHIM Syndrome-linked CXCR4 mutations drive osteoporosis.
Nat Commun. 2023;14(1):2058.
PubMed
Google Scholar
P
Li Z
,
Xu X
,
Weiss ID
,
Jacobson O
,
Murphy PM
.
Pre-treatment of Allogeneic Bone Marrow Recipients with the CXCR4 Antagonist AMD3100 Transiently Enhances Hematopoietic Chimerism without Promoting Donor-specific Skin Allograft Tolerance.
Transpl Immunol. 2015.
PubMed
Google Scholar
McDermott DH
,
Liu Q
,
Velez D
,
Lopez L
,
Anaya-O'Brien S
,
Ulrick J
,
Kwatemaa N
,
Starling J
,
Fleisher TA
,
Priel DALong
, et al.
A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor.
Blood. 2014.
PubMed
Google Scholar
I
Bachelerie F
,
Ben-Baruch A
,
Burkhardt AM
,
Combadiere C
,
Farber JM
,
Graham GJ
,
Horuk R
,
Sparre-Ulrich AHovard
,
Locati M
,
Luster AD
, et al.
International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors.
Pharmacol Rev. 2014;66(1):1-79.
PubMed
Google Scholar
A
Li W
,
Liu C
,
Burns N
,
Hayashi J
,
Yoshida A
,
Sajja A
,
González-Hernández S
,
Gao J-L
,
Murphy PM
,
Kubota Y
, et al.
Alterations in the spatiotemporal expression of the chemokine receptor CXCR4 in endothelial cells cause failure of hierarchical vascular branching.
Dev Biol. 2021.
PubMed
Google Scholar